ARTICLE | Distillery Therapeutics
Otologic
July 17, 2018 5:38 PM UTC
Mouse studies suggest CLRN1 gene therapy could help treat hearing loss in Usher syndrome type 3A, which is caused by CLRN1 mutations. In a hair cell-specific CLRN1 knockout mouse model of Usher syndro...
BCIQ Company Profiles
Institut National de la Sante et de la Recherche Medicale (INSERM)
BCIQ Target Profiles